PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 35: Articles 17001-17500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Health impacts of family planning.
  2. Health rationale for family planning.
  3. Health rationale for surgical contraception in Egypt.
  4. Hemorrheology and fibrinolytic response in women taking oral contraceptive pills.
  5. Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives.
  6. Hepatic vein thrombosis (Budd Chiari Syndrome): possible association with the use of oral contraceptives.
  7. Heterosocial anxiety and contraceptive behavior.
  8. High risk pregnancy: an undisputed indication for birth control in Islam.
  9. High-dose estrogen-progestagen oral contraceptives: a risk factor for aneurysmal subarachnoid hemorrhage?
  10. Hispanic adolescent conception and contraception profiles.
  11. The history of contraception: seven choices.
  12. History of contraceptive practices.
  13. Hormonal contraception and general pathology. [Contraception hormonale et pathologie generale.]
  14. Hormonal contraception and its complications. [Hormonalna antikoncepcia a jej komplikacie.]
  15. Hormonal contraception and other drug treatments. [Hormonaalinen ehkaisy ja muu laakehoito.]
  16. Hormonal contraception in female competitive athletes. [Hormonale Kontrazeption bei sporttreibenden Frauen.]
  17. Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism. [Hormonal kontraception med etinylostradiol og gestoden: Effekt pa glukosetolerans og lipidmetabolisme.]
  18. Hormonal contraception. [La contraception hormonale.]
  19. Hormonal contraceptives and the risk of cancer. [Contraception hormonale et risque de cancer.]
  20. Hormonal steroid contraception: a critical review of recent advances.
  21. Household survey of Mexico City: psychosocial study of adolescents, their sexual and contraceptive knowledge and practice. Final report of the first stage of probabilistic household sample for the investigation "Mexico City adolescents. A Psychosocial Study of Contraceptive Practice and Unwanted Pregnancy". [Encuesta de hogares de la ciudad de Mexico: estudio psicosocial de las adolescentes, sus conocimientos y practicas sexuales y anticonceptivos. Reporte final de la primera etapa del muestreo probabilistico de hogares de la investigacion: "Adolescentes en la Ciudad de Mexico: un Estudio Psicosocial de las Practicas Anticonceptivas y Embarazo no Deseado".]
  22. How many children? Dilemmas of family planning.
  23. How to stimulate the establishment of the family planning programme in Pt Gudang Garam, Kediri, Indonesia.
  24. Human populations and the world conservation strategy. Report from the Working Group on Population and Natural Resources of the IUCN Commission on Ecology in cooperation with the International Planned Parenthood Federation.
  25. Husband-wife communication and contraceptive behaviour.
  26. Hyperinhibition syndrome following the use of contraceptive tablets. [Sindrom gipertormozheniia posle primeneniia protivozachatochnykh tabletok.]
  27. Illustrations of PVO integrated family planning/health projects.
  28. Immigrant women at the health center. Monitoring of pregnancy and contraception. [Innvandrerkvinner pa helsestasjonen. Svangerskapskontroll og prevensjon.]
  29. Immune status of women taking Chinese-made contraceptives.
  30. Immunocompetence of marginally nourished women on hormonal contraceptives.
  31. Immunological approaches to contraception.
  32. Immunological aspects of the development of contraceptive vaccines. [Immunologiske aspekter ved utvikling av prevensjonsvaksiner.]
  33. The impact and efficiency of the family planning programme in Bangladesh.
  34. The impact and efficiency of the family planning programme in Peninsular Malaysia.
  35. The impact and efficiency of the family planning programme in Thailand.
  36. The impact and efficiency of the family planning programme in the Republic of Korea.
  37. The impact of CSM on contraceptive prevalence: an examination of currently available evidence. Project description. A SOMARC special study.
  38. The impact of family planning program activity on fertility.
  39. The impact of family planning training of nursing school faculty in Brazil.
  40. The impact of social marketing programs on contraceptive prevalence: a cross-section time-series analysis.
  41. The impact of television on the family planning attitudes of an urban Nigerian audience: the NTA/ENUGU experience.
  42. The impact of the contraceptive transition on the recent and future development of fertility in Flanders.
  43. The impact of the Health Belief Model, desire for control, perceived control, and modifying variables on young women's contraceptive use.
  44. Impact study of Thailand's National Family Planning Programme on fertility decline in the first half of the Fifth National Socio-Economic Development Plan (1982-1986)
  45. Impacts of IEC activities and awareness of social support policies on family planning acceptance.
  46. Impaired glucose tolerance in women using oral contraceptives: United-States, 1976-1980.
  47. Implications of AIDS for domestic family planning programs.
  48. The importance of family planning in reducing maternal mortality.
  49. Improving contraceptive acceptability: role of sex counselling.
  50. Improving contraceptive practices -- an experiment in camp settings.
  51. Improving the utilization and self-sufficiency of Yayasan Kusuma Buana's urban family planning clinics: problem analysis. Final report.
  52. Incentives and disincentives in family planning programs.
  53. Incentives, disincentives, and family planning.
  54. Incentives, disincentives, and family planning: selective bibliography for countries in the ESCAP region: annotated.
  55. Incorporating family planning within primary health care.
  56. Indonesia: an overview of the national family planning program.
  57. Indonesian Planned Parenthood Association in central Java.
  58. Infertility and sexually transmitted disease: major problems in maternal and child health and family planning.
  59. Influence of family planning counseling in an adolescent clinic on sexual activity and contraceptive use.
  60. The influence of health care on contraceptive acceptance in rural Mexico.
  61. The influence of high- and low-dose hormonal contraceptives on HDL and total cholesterol levels.
  62. Influence of human chorionic gonadotropin (hCG) in combination with a 500 calorie diet on clinical and laboratory parameters in premenopausal women with and without hormonal contraception. [Einfluss von menschlichem Choriongonadotropin (hCG) in Kombination mit einer 500-kcal-Reduktionsdiat auf Klinik und Laborparameter von pramenopausalen Frauen mit bzw. ohne hormonale Kontrazeption.]
  63. Influence of microwaves on the frequency of human peripheral blood lymphocyte sister chromatid exchange in male contraception.
  64. The influence of physiologic variables and oral contraceptives on bioelectric impedance.
  65. Information education communication in the field of population and family planning: husband-wife communication and practice of family planning.
  66. Information, education and communication and family planning in Ghana: the case for the mass media.
  67. Injectable contraceptives--sterilization alert. News flash.
  68. Injectable contraceptives: the use of reusable versus disposable needles and syringes.
  69. Insertion and removal of NORPLANT contraceptive implants by physicians and nonphysicians in an Indonesian clinic.
  70. Integrated family planning and health in Indonesia.
  71. Integrated Family Planning and Parasite Control Project of Tanzania.
  72. Integrated Family Planning Nutrition and Parasite Control (Pilot Project) in Ghana, March 1987.
  73. Integrating family planning into group medicine practices: legal, health, and economic implications.
  74. Integration and disintegration: the case of family planning in Haiti.
  75. Integration in family planning programs. [La integracion en los programas de planificacion familiar.]
  76. Integration of family health and family planning into the curriculum of the State School for Midwives in Dakar. Continued. [Integration de la sante familiale et planification familiale dans le curriculum de l'Ecole des Sages-Femmes d'Etat de Dakar (suite)]
  77. The integration of family planning with health and development.
  78. Interim evaluation of the Family Planning Self-Reliance Project, Costa Rican Demographic Association.
  79. An international comparison of unintended pregnancy, contraceptive practice and family planning services.
  80. International Conference on Better Health for Women and Children Through Family Planning 5-9 October, 1987 in Nairobi, Kenya, basic documents.
  81. The International Conference on Better Health for Women and Children through Family Planning.
  82. International statements on family planning and population development [letter]
  83. Interpersonal factors in premarital contraception.
  84. Interviewer's manual for use with model "a" questionnaire for high contraceptive prevalence countries.
  85. Interviewer's manual for use with model "b" questionnaire for low contraceptive prevalence countries.
  86. Intra-uterine contraception in the year 2001.
  87. INTRAH Glossaire de planification familiale / INTRAH Glossary of family planning terms.
  88. Intranasal LRH-A for contraception by inhibition of ovulation: observation of 10 cases.
  89. Intrauterine contraception with levonorgestrel: first-year clinical performance study.
  90. Intrauterine contraception: advances and future prospects.
  91. Intrauterine contraception: technical advances, future prospects.
  92. Intrauterine contraceptive devices: MR imaging.
  93. Intrauterine steroid contraceptives.
  94. The introduction of birth control in the city of Stavanger, 1900-1935. [Gjennombrotet for fodselsregulering i Stavanger, 1900-1935.]
  95. The investigation of the spumescence of vehicles for vaginal contraceptive preparations.
  96. Involving males in contraceptive responsibility: evaluation of a communication program.
  97. Involving men, family planning's "other half".
  98. Isolated angiitis of the brain in a young female on the contraceptive pill.
  99. Issues of medical quality assurance in Voluntary Surgical Contraception.
  100. Japan: declining fertility due mainly to marriage trends, birth control use.
  101. Jiang Sannu's home clinic for family planning.
  102. Joint statement: contraceptive methods and human immunodeficiency virus (HIV)
  103. K.A.P. survey of contraception in Bhopal and surrounding villages.
  104. Keynote speech: community-based distribution in family planning programmes.
  105. KIPH major research activities. A study on organizational issues of community participation in Korean National Family Planning Programme.
  106. Knowledge and use of contraception.
  107. Lack of effects of hospitalization and oral contraceptives on DST results in control subjects.
  108. Lactation and lactation related variables: contraception and fertility: an overview of data problems and world trends.
  109. Leadership in primary health care--family planning nurses.
  110. Lipid metabolism and hormonal contraception. [Metabolismo lipidico e contraccezione ormonale.]
  111. Lipid metabolism and the contraceptive pill.
  112. Log-linear analysis of the personal factors affecting the level of fertility among contraceptive using women. On the women who use contraceptives for the purpose of infertility.
  113. Long-acting injectable contraceptives -- current status.
  114. Low-dose oral contraception and thrombosis.
  115. Luteinizing hormone-releasing hormone analogs: female contraception.
  116. Maendeleo ya wanawake programme of community-based distribution of contraceptives, Kenya.
  117. Male contraception and AIDS prevention. The need for involvement by Kansas physicians.
  118. Male contraception in 1987. [Contraception masculine en 1987.]
  119. Male contraception. [Contraception masculine.]
  120. Male contraception: in the near future? [La contraception masculine: un futur proche?]
  121. Male contraception: possible endocrine approaches.
  122. Management of family planning programmes by objectives.
  123. The management of family planning programs: Profamilia's experience.
  124. Managing contraceptive pill patients. 5th ed.
  125. Marketing family planning services in New Orleans.
  126. Mass media coverage of family planning and population issues in Nigeria.
  127. Maternal and child health and family planning services in the Sudan.
  128. Maternal and child health and family planning: perceptions and links.
  129. Maternal and child health care: a key step for family planning.
  130. Maternal child health and family planning in Tanzania: a bibliography.
  131. Maternal-child health and family planning in Ghana.
  132. Matlab: dramatic increase in proportion of women who practice contraception in order to space births.
  133. Mauritius Contraceptive Prevalence Survey, 1985: final report.
  134. The measurement of family planning inputs.
  135. Measures of influence of family planning program on fertility.
  136. Measuring the causal impact of family planning program effort on fertility: a consideration of some methodical issues.
  137. Measuring the impact of family planning services in Tanzania.
  138. Mechanical contraception in the year 2001.
  139. Medical and contraceptive sterilization in the United States: similarities and differences in their rationale.
  140. Medical aspects of contraception.
  141. Men's reproductive health services in family planning settings: a pilot study.
  142. Menstrual cycle and fertility after using hormonal and intrauterine contraceptive agents. [Menstrualnyi tsikl i fertilnost posle primeneniia gormonalnykh i vnutrimatochnykh protivozachat chnykh sredstv.]
  143. Metabolic effects of combined oral contraceptive preparations.
  144. Metabolic effects of contraceptive pills. [Ehkaisypillereiden metaboliset vaikutukset.]
  145. Metabolic effects of oral contraceptives. [Stoffwechselwirkungen oraler Kontrazeptiva.]
  146. Method switching among IUD- and OC-users during the first year of use at a public family planning clinic in Finland.
  147. Methodological problems in evaluation of family planning, maternal and child health programmes in Africa.
  148. Methodology of family planning target setting and population projection. Part I.
  149. Methodology of family planning target setting and population projection. Part II.
  150. The midwife and family planning. [La sage-femme et la planification familiale.]
  151. Might generic OCs create contraceptive price war?
  152. Migraine and oral contraception.
  153. Migration, fertility, and contraception in Baja California (some working hypotheses) [Migracion, fecundidad y anticoncepcion en Baja California (algunas hipotesis de trabajo)]
  154. Minors' rights to contraception.
  155. Mobilizing resources to meet demand for family planning.
  156. Model "a" questionnaire with additional health questions and commentary for high contraceptive prevalence countries.
  157. Model "A" questionnaire with commentary for high contraceptive prevalence countries.
  158. Model "b" questionnaire with additional health questions and commentary for low contraceptive prevalence countries.
  159. Model "B" questionnaire with commentary for low contraceptive prevalence countries.
  160. A model to investigate interactions obtunding oral contraceptive activity.
  161. Modeling the inverse association between breastfeeding and contraceptive use.
  162. Modernity and family planning behavior in urban Indonesia.
  163. Molding of the uterus following intrauterine contraceptive device removal: documentation by hysterosalpingography.
  164. Monitoring of social welfare programmes: family planning perspective.
  165. Mortality among oral contraceptive users.
  166. The Moslem woman and her contraception. [La femme musulmane et sa contraception.]
  167. The most common choices for those desiring to practice contraception. [As opcoes mais comuns para quem deseja praticar a anticoncepcao.]
  168. Motives for not consciously using contraception and the attitude toward pregnancy of young women less than 18 years of age. [Ursachen der Nichtwahrnehmung der bewussten Familienplanung und Einstellung zur Schwangerschaft bei Jugendlichen unter 18 Jahren.]
  169. A multicentred pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera.
  170. Multilateral support for family planning.
  171. Multiphasic oral contraceptives: efficacy and metabolic impact.
  172. Multivariate areal analysis of the impact and efficiency of the family planning programme in peninsular Malaysia.
  173. National Conference on Community-Based Health Care and Family Planning. The role of external management input in community-based health care.
  174. National family planning activities in Zambia.
  175. National Family Planning Program in Indonesia: successes, challenges, and future prospect.
  176. The National Family Planning Program management information system.
  177. National Maternal-Child Health and Family Planning Survey, PNSMIPF -- Brazil, 1986. [Pesquisa Nacional sobre Saude Materno-Infantil e Planejamento Familiar, PNSMIPF--Brasil, 1986.]
  178. National population, family planning and future development.
  179. National situation of population and family planning programmes and future indications: the case of Nigeria.
  180. National survey on family planning, fertility and health of the population of Morocco (ENPS) 1987: preliminary report. [Enquete Nationale sur la Planification Familiale, la Fecondite et la Sante de la Population au Maroc (ENPS) 1987: rapport preliminaire.]
  181. Natural family planning in Nepal.
  182. Natural family planning indicators of ovulation.
  183. Natural family planning: fact sheet for family planning providers.
  184. Natural family planning: findings from the Bangladesh program.
  185. Natural family planning: findings from the family life programme in Eldoret, Kenya.
  186. Natural family planning: findings from the Korean Happy Family Movement.
  187. Natural family planning: findings from the Tamil Nadu program, South India.
  188. Nature's contraceptive.
  189. Nepal Fertility and Family Planning Survey report, 1986.
  190. New approaches to Family Planning Programme.
  191. New approaches to family planning programme.
  192. New approaches to family planning programme: Indian perspective.
  193. New approaches to family planning programme; Indian perspective.
  194. New approaches to male sterilisation: application of percutaneous puncture to vas deferens on male contraception.
  195. The "new beginning" in Pakistan's family planning programme.
  196. New charter hits family planning.
  197. New developments in intrauterine contraception.
  198. New developments in oral contraceptives.
  199. A new methodology for evaluating family planning programs.
  200. New methods of vaginal contraception. [Les nouvelles methodes de contraception vaginales.]
  201. New model intrauterine contraceptive device --the Copper T 380 Ag. [Nov model vutrematochen kontratseptiven pesar -- Copper T 380 Ag.]
  202. New paths to family planning: The Family Planning Private Sector Programme of Kenya.
  203. New regimen of injectable contraceptives.

     

  204. New ways to deliver family planning services in sub-Saharan Africa: a regional conference.
  205. Non-hormonal methods of female contraception. [Les methodes non hormonales de contraception feminine.]
  206. Non-use and reasons for non-use of contraception: Pakistan Contraceptive Prevalence Survey, 1984-85.
  207. Nonsurgical interruption of early pregnancy using the antiprogesterone RU 486 -- an effective contraceptive. [Nechirurgicke preruseni casneho tehotenstvi pomoci antiprogesteronu RU 486 -- ucinneho kontragestiva.]
  208. Norethisterone contraceptive microspheres.
  209. Norplant as a contraceptive seen from the midwife's viewpoint. [Norplant som preventivmedel sett ur en barnmorskas synvinkel.]
  210. Norplant contraceptive implants.
  211. Norplant contraceptive implants: rods versus capsules.
  212. Norplant: a new alternative in family planning. [Norplant: una nueva alternativa en planificacion familiar.]
  213. Note on psychological differences between 18-yr-old Finnish females who use vs do not use oral contraceptives.
  214. Nursing intervention to assist patients' decision making with respect to family planning.
  215. Odds ratio analysis of factors affecting the use of contraception.
  216. Omnibus study on family planning, March 1987, report on data from females.
  217. Omnibus study on family planning, March 1987, report on data from males.
  218. On an ideology for the contraceptive survey. [A ideologia da pesquisa em contracepcao.]
  219. On family planning policy in Brazil. [Sobre a politica de planejamento familiar no Brasil.]
  220. On the epidemiology of oral contraceptives and disease.
  221. On the history of contraceptive steroids. [Zur Geschichte der Empfangnisverhutung mit Steroiden.]
  222. On the question of human reproduction today: a critical analysis of contraception in Brazil. [A questao da reproducao humana hoje -- uma analise critica da contracepcao no Brasil.]
  223. Once-a-month injectable contraceptives.
  224. Ongoing community-based/alternative health/family planning delivery programmes in Sub-Saharan Africa: an overview.
  225. The opinion of low-income women living in an interior city on family planning. [Opiniao de mulheres de baixa renda, residentes em cidade do interior sobre planejamento familiar.]
  226. Oral contraception and gender affect protein S status.
  227. Oral contraception in Bangladesh: social marketing and the importance of husbands.
  228. Oral contraception in perspective. Thirty years of clinical experience with the pill.
  229. Oral contraception: evolution of concepts over the last thirty years. [Contraception orale: evolution des concepts depuis 30 ans.]
  230. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass.
  231. Oral contraceptive agents.
  232. Oral contraceptive compliance in rural Colombia: daily use, personal and provider characteristics.
  233. Oral contraceptive drug product labeling. Notice of the Food and Drug Administration. Dated 13 March 1987.
  234. Oral contraceptive estrogen content and adverse effects: has a dose-response relationship been established?
  235. Oral contraceptive failure secondary to dentally prescribed drugs: fact or fiction?
  236. Oral contraceptive induced paraballism.
  237. Oral contraceptive interaction with cyclosporin [letter]
  238. Oral contraceptive steroid induced platelet coagulant hyperactivity: dissociation of in vivo and in vitro effects.
  239. Oral contraceptive therapy: effects on the oral tissues.
  240. Oral contraceptive usage and arterial hypertension: a study in a maternal-child health center in Algiers. [Utilisation des contraceptifs oraux et hypertension arterielle: etude dans un Centre de Protection Maternelle et Infantile d'Alger.]
  241. Oral contraceptive use and breast cancer [letter]
  242. Organizing for community participation in a rural health/family planning project: the Oyo State, Nigeria experience.
  243. Organizing for effective family planning programs.
  244. The origin of intrauterine contraception. [Poczatki antykoncepcji wewnetrzmacicznej.]
  245. Outlook 'bleak' for developing contraceptive methods in U.S.
  246. Outreach strategy for natural family planning.
  247. Ovarian follicular development in oral contraceptive cycles.
  248. Ovarian function with minidose oral contraception: the ultrasound morphology of the ovaries and endocrinology. [Fonction ovarienne sous contraception orale minidosee: morphologie echographique des ovaires et hormonologie.]
  249. Ovarian pregnancy and intrauterine contraception. [Ovariel graviditet og intrauterin kontraception.]
  250. Ovarian pregnancy associated with the intra-uterine contraceptive device: a survey of two decades.
  251. Ovarian pregnancy in association with a Copper 7 intrauterine contraceptive device.
  252. Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
  253. An overall evaluation of the USAID/Bangladesh Family Planning Services Project (388-0050), key issues, and future assistance, March 1986.
  254. An overview of the Federation of Family Planning Associations, Malaysia.
  255. Overview of the legal obstacles to CBD of contraceptives in Sub-Saharan Africa.
  256. Pain reduction during and after insertion of an intrauterine contraceptive device.
  257. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
  258. Paramedic insertion of intrauterine device in a Malaysian family planning clinic.
  259. Parenteral contraceptive drugs: depot progestins. [Parenterale empfangnisverhutende Praparate: Depotgestagene.]
  260. Parliament and the demographic question: a study of the debate over birth control and family planning in the National Congress. [O Parlamento e a questao demografica: um estudo do debate sobre controle de natalidade e planjamento familiar no Congresso Nacional.]
  261. Patterns and covariates of contraceptive method choice in Korea.
  262. People's participation in family planning.
  263. Peptides and neuropeptides as possible contraceptive agents.
  264. Perceived versus real risks of oral contraceptives.
  265. Perforation of the uterus by a contraceptive device. [Perforatsiia matki kontratseptivami.]
  266. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
  267. A person perception experiment examining the effects of contraceptive behavior on first impressions.
  268. Persons, sex, and contraceptives.
  269. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
  270. Pharmacologic considerations for patients taking oral contraceptives.
  271. Phasic contraceptive pills and functional ovarian cysts.
  272. Physically, mentally disabled teens require special contraceptive care.
  273. The physico-chemical evolution of copper intrauterine contraceptive devices. [Devenir physico-chimique des sterilets au cuivre.]
  274. The place of progesterone in human contraception.
  275. Place of radiology in intrauterine contraception. [Place de la radiologie dans la contraception intra-uterine.]
  276. Planned Parenthood Association v. City of Cincinnati, 1 July 1987.
  277. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
  278. Plasma renin activity, blood pressure and body weight during two years' oral contraception with two different low-estrogen combinations.
  279. Plenary session: the Zimbabwe National Family Planning Council's CBD program.
  280. Pointers on progress in family planning in Portugal.
  281. Policy and political issues in implementing family planning programs in LDCs: a PVO perspective.
  282. The policy and programme implications of promoting family planning for better health.
  283. The politics of contraception: the view from Tokyo.
  284. The politics of family planning in developing countries: a note for PVOs.
  285. The Population Council licenses Gynomed Pharmaceutical Inc. to sell new, improved copper-bearing IUD in U.S., expanding contraceptive options available to American women. [News release]
  286. The population explosion and the contraceptive ethos.
  287. Population growth and family planning in India.
  288. Population: oral contraception and AIDS [memorandum]
  289. Positive images: a new approach to contraceptive education. 2nd ed.
  290. Possible link between long-term oral contraceptive use and cervical cancer. [Posible vinculo entre el uso a largo plazo de la pildora y el desarrollo del cancer cervical.]
  291. Possible reduction of cervical cancer by use of barrier-type contraceptives.
  292. Post coital contraception. [La contraception post-coitale.]
  293. Post-ovulatory methods of contraception.
  294. Post-partum contraception.
  295. Postcoital contraception. [La contraception post-coitale.]
  296. Postcoital contraception. [Yhdynnan jalkeinen ehkaisy.]
  297. Postcoital contraception: a cover-up story.
  298. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
  299. The potential contribution of family planning programs to AIDS prevention in developing countries.
  300. The potential impact of improvements in contraception on fertility and abortion in Western countries.
  301. Potential impacts on fertility in western countries of improvements in contraception.
  302. Prediction factors of contraceptive behavior of single girls aged 15-19. Prediction through theory formation and testing by analogy with the Fishbein model. [Predictiefactoren van contraceptiegedrag bij ongehuwde meisjes van 15- tot 19 jaar. Predictie via theorievorming en toetsing naar analogie met het Fishbein-model.]
  303. Predictors of contraceptive continuation among urban family planning acceptors of Bangladesh.
  304. Pregnancy interruption and childbirth after contraception. [Raskaudenkeskeytyksen ja synnytyksen jalkeinen ehkaisy.]
  305. Preliminary report of a study evaluating the effectiveness of the polyvinyl benzalconium chloride contraceptive sponge.
  306. A preliminary study into the efficacy of progesterone suppositories as a contraceptive for women with severe premenstrual syndrome.
  307. Premarriage education in family planning should begin in puberty.
  308. Prescribing information: Lippes Loop intrauterine contraceptive device. [Package insert]
  309. The presence of endometrial cells in cervical smears in relation to the day of the menstrual cycle and the method of contraception.
  310. The press and family planning. [La prensa escrita y la planificacion familiar.]
  311. Prevalence of surgical contraception: PNSMIPF, 1986. [Prevalencia da contracepcao cirurgica, PNSMIPF - 1986.]
  312. Preventing the spread of AIDS in less developed countries: lessons learned from family planning outreach programs.
  313. Prevention of infection in voluntary surgical contraception.
  314. Principles and evolution of progestin use in contraception. [Principes et evolution des methodes de traitement progestatif en contraception.]
  315. Priority research projects on family planning technique during the "Seventh Five-Year Plan" period.
  316. PRO-PATER'S experience in male surgical contraception.
  317. Problems associated with counselling for surgical contraception - UBTH experience.
  318. Problems in disseminating family planning information.
  319. Proceedings. Conference on contraceptive technology update, 2-3 November, 1986, Hotel Sonargaon, Dhaka.
  320. PROFAMILIA studies the effectiveness of contraceptive marketing programs in Colombia. [PROFAMILIA estudia la eficacia de los programas de comercializacion de anticonceptivos en Colombia.]
  321. Progestagens as contraceptives. [Progestagene zur Empfangnisverhutung.]
  322. Progestational contraception. [La contraception progestative.]
  323. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study [letter]
  324. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study. Reply to letter to the editor [letter]
  325. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study) [Contraception progestative par l'acetate de chlormadinone chez des femmes a risque vasculaire: (etude gyneco-endocrinienne, metabolique et vasculaire)]
  326. Progestogen potency in oral contraceptive pills.
  327. Prognosis of ovulation based on contraceptive methods. [Ovulaation ennustamiseen perustuvat ehkaisymenetelmat.]
  328. Program issues in the provision of family planning services.
  329. Progress in the development of once-a-month injectable contraceptives.
  330. Project description and budget: Indonesia-21, modification no 10. Family planning for industrial workers.
  331. A project proposal on the integrated family planning, health education and parasite control.
  332. The PROJUSE simulation model for determining family-planning objectives.
  333. Prolonged-action contraceptives. [Kontratsevtivy prolongirovannogo deistviia.]
  334. Promoting family planning work in Xiaqidu township by establishing a family planning association in each village.
  335. Promotion of a family planning program: the Taiwan model.
  336. Promotion of breastfeeding and family planning in the Honduras Social Security Institute (IHSS): an operations research project.
  337. The prophylactic properties of the Today sponge and other spermicide containing contraceptives.
  338. A prospective multicenter trial of the ovulation method of natural family planning. V. Psychosexual aspects.
  339. A prospective study of the acceptability of Today vaginal contraceptive sponge among Malaysian women.
  340. Prospective study on the use of local contraceptive methods by adolescents. [Estudio prospectivo del uso de metodos anticonceptivos locales en adolescentes.]
  341. Prostaglandins and intrauterine contraceptive device.
  342. Protective effect of the contraceptive sponge against STDs in Thailand.
  343. The provision of contraceptive methods during lactation and support for breast-feeding: policies and practices.
  344. The provision of natural family planning services at public health centers in Colombia.
  345. Psychiatric symptoms and transient cognitive impairment in an adolescent with oral contraceptive-induced chorea.
  346. Psychological correlates of contraceptive use and misuse--a cross cultural study.
  347. Psychology as vital as technology in natural family planning.
  348. The psychology of contraception. [Ehkaisyn psykologia.]
  349. Psychosocial aspects of contraceptive sterilization.
  350. Public sector contraceptive development: history, problems, and prospects for the future.
  351. Publicity and education are fundamental to China's family planning programme.
  352. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report.
  353. Purchasers of oral contraceptives in a social marketing program in Honduras: final report.
  354. PVO perspectives on integrating family planning into primary health care.
  355. Qualitative methods for program evaluation, a manual for health, family planning and social service programs. [Metodos cualitativos para la evaluacion de programas, un manual papra programas de salud, planificacion familiar y servicios sociales.]
  356. Quality care in international family planning: a feminist contribution.
  357. Quantitative transcervical uterine cultures in asymptomatic women using an intrauterine contraceptive device [letter]
  358. Quantitative transcervical uterine cultures in asymptomatic women using an intrauterine contraceptive device. In reply [letter]
  359. Questions and answers about family planning. [Service Provider Manual - Draft]
  360. Racial differences in contraceptive choice: complexity and implications [tables]
  361. Racial differences in the perception of contraception option attributes.
  362. Rare case of an improperly inserted contraceptive device. [Riaduk sluchai na nepravilno postaven kontratseptiven pesar.]
  363. Reach and effectiveness of media popularising family planning programme: a study conducted in Uttar Pradesh.
  364. Reasons for discontinuing temporary family planning methods.
  365. Reasons for initial and subsequent visits to a public health teen family planning clinic.
  366. Reassessing the contraceptive effect of breastfeeding.
  367. Recent and future developments in contraception -- an overview.
  368. The reduction in risk of ovarian cancer associated with oral-contraceptive use.
  369. Regional lipiodolized chemotherapy for cholangiocarcinoma associated with oral contraceptives.
  370. Relationship between prolactin and pituitary gonadotrophin and its role in birth control.
  371. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use.
  372. Relationships between contraception and gynecologic infections. [Relazioni tra contraccezione e flogosi genitali nella donna.]
  373. The relative importance of family planning and development for fertility reduction: critique of research and development of theory.
  374. Relative risks of oral contraceptive usage [letter]

     

  375. Relative risks of oral contraceptive usage.
  376. Relative risks of oral contraceptive usage. Reply of the authors [letter]
  377. The renin-angiotensinogen reaction during pregnancy and oral contraception: estimation of kinetic parameters by an autologous plasma renin assay.
  378. Report of a meeting on contraceptive methods and HIV infection, Geneva, 29-30 June, 1987.
  379. Report on birth order distribution as a family planning programme evaluation indicator.
  380. Report on integrated maternal and child health/family planning programmes in Africa.
  381. Report on integrated maternal and child health/family planning programmes.
  382. Report on the eighth annual workshop in management and training for family planning and primary health care in Africa, June 1-26, 1987.
  383. Report. Conference on Contraceptive Technology Update, 2nd and 3rd November, 1986, Sonargaon Hotel, Dhaka.
  384. Reports on the existing national population, family planning and the future direction: the national population policy.
  385. Reproduction and contraception. Third National Prevalence Survey 1986. [Reproduccion y contracepcion. Tercera Encuesta Nacional de Prevalencia 1986.]
  386. Reproductive health and health benefits of family planning.
  387. Reproductive health during adolescence: AIDS/STD and contraception.
  388. Reproductive rights and wrongs: the global politics of population control and contraceptive choice.
  389. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico.
  390. The requirements for the ideal contraceptive.
  391. Research on the planning of family size (1985), Part 2. [Pruzkum planovani rodicovstvi (1985)--II.]
  392. Resistant ovary syndrome following oral contraception. [Sindrome de "ovario resistente" tras toma de anticonceptivos orales.]
  393. Resolution on family planning, 10 July 1987.
  394. Results of the Survey: Policy and Procedures Concerning Distribution of Contraceptives. [Resultats de l'Enquete: la Politique et les Procedures en Matiere de Distribution de Contraceptifs.]
  395. Reversible contraception for women at high risk of fetal anomalies.
  396. A review of population projections and the family planning program in Indonesia 1980-2000 (by the new component method): part I. 2nd edition.
  397. Risk factors for Chlamydia trachomatis infection of the cervix: a prospective study of 2000 patients at a family planning clinic.
  398. The risk of an unwanted birth: the changing context of contraceptive sterilization in the U.S.
  399. Risk-benefit analysis of contraception with steroids. [Risiko-Nutzen-Analyse der Empfangnisverhutung mit Steroiden.]
  400. Risks and benefits of hormonal contraception. [Hormonaalisen ehkaisyn hyodyt ja riskit.]
  401. Risks of intrauterine contraception (IUD) [I rischi della contraccezione con dispositivi intrauterini.]
  402. Risks of oral contraceptives [letter]
  403. The role of availability and accessibility in family planning adoption: Egypt 1984.
  404. The role of domiciliary injectable contraception in the government of Bangladesh system: a mid-term assessment.
  405. The role of information, education, and communication in family planning service delivery in Tunisia.
  406. The role of international agencies, governments, and the private sector in the diffusion of modern contraception.
  407. The role of private physicians and clinics in Third World family planning.
  408. The role of sterilization in family planning in the German Democratic Republic. [Zum Stellenwert der irreversiblen Kontrazeption (Sterilisation) im Rahmen der Familienplanung in der DDR.]
  409. The role of the family in sexual and contraceptive behavior of the adolescent in Mexico City. [Que papel juega la familia en la conducta sexual y anticonceptiva de la adolescente en la Ciudad de Mexico?]
  410. The role of the International Planned Parenthood Federation in setting international medical standards.
  411. The role of the village midwives in family planning in Khartoum.
  412. Role of voluntary and non-governmental organizations in the national family planning programme.
  413. Safe motherhood through family planning.
  414. Safeguards in intrauterine contraception.
  415. School pupils knowledge of contraception: a study at the conclusion of compulsory education. [Skoleelevers viden om praevention. En undersogelse ved undervisningspligtens ophor.]
  416. The second billion: population and family planning in China.
  417. The second contraceptive revolution: birth control in France from 1950 to 1985. [La seconde revolution contraceptive: la regulation des naissances en France de 1950 a 1985.]
  418. Selective screening for Chlamydia trachomatis infection in nonurban family planning clinics in Wisconsin.
  419. The selling of health and family planning.
  420. The sensitivity of the natural rate of increase to changing patterns of breastfeeding and contraception.
  421. Serum concentrations of immunoglobulins and complement components in women using an intra-uterine contraceptive device (IUCD)
  422. Serum magnesium in women during pregnancy, while taking contraceptives, and after menopause.
  423. Service station established at villages and towns in Fufeng County pushed forward the family planning program there.
  424. Sex education and family planning services for young adults: alternative urban strategies in Mexico.
  425. Sex education. The dissemination of family planning services and contraceptives in public school.
  426. Some ethical issues in international family planning programs.
  427. Some problems related to family planning: observations from a Bihar village?
  428. Spiritual civilization in family planning advocated by government.
  429. Spousal veto over family planning services.
  430. Sri Lanka Contraceptive Survey, 1985: an innovative approach to the study of traditional and modern contraceptive practices.
  431. Staffing patterns in family planning clinics: which model is best?
  432. Standardized test of CBD distributor family planning knowledge.
  433. Statement of the American College of Obstetricians and Gynecologists on Depo-Provera use as a contraceptive.
  434. Statement on breast feeding, fertility and contraception.
  435. Statement on steroidal oral contraception.
  436. A statistical analysis of patterns of contraceptive practice in a local population.
  437. Status and potential of family planning in Pakistan.
  438. STDs, IVF, and barrier contraception [letter]
  439. Stimulating private sector investment in family planning in Peru.
  440. Strangulating small bowel obstruction due to an intrauterine contraceptive device.
  441. Strategies for increasing contraceptive use in factories in Barbados. Project proposal.
  442. Strengthening of Family Planning Services. Kenya-14: project description and budget.
  443. A study of social-psychological factors affecting fertility and family planning acceptance.
  444. Study of the response of acceptors to the attributes of Norplant contraceptive subdermal implants and to changes that occur with the use of the method. Experience of post-partum and interval acceptors. Answers to open-ended questions. Report submitted to the Population Council by CEMICAMP, in fulfillment of Grant I87.07A (Supplement to awards No. I85.12A and I86.08A)
  445. Study of the response of acceptors to the attributes of Norplant contraceptive subdermal implants and to changes that occur with use of the method. Answers to open-ended questions. Report submitted to the Population Council by CEMICAMP, in fulfillment of Grants No. I85.12A and I86.08A.
  446. Study of the response of acceptors to the attributes of Norplant contraceptive subdermal implants and to changes that occur with use of the method. Experience of post-partum and interval acceptors. Answers to pre-coded questions. Second of a three-part report submitted to the Population Council by CEMICAMP, in fulfillment of Grants No. I85.12A and I86.08A.
  447. Study on the influence of etretinate on biologic activity of oral contraceptives [letter]
  448. Study on the restoration of ovulation in women after long-term use of long-acting monthly oral contraceptives: 16 methylene chlormadinone compound.
  449. Subdermal implants -- a slow-releasing contraceptive steroid.
  450. Successful implementation of family planning programme depends on expansion and strengthening of IEC programmes.
  451. A summary of family planning activities during the last three economic and social development plans (1974-1986) [Bilan des activites de P. F. durant les trois derniers plans economiques et sociaux (1974/1986)]
  452. The suppression of ovarian function by the new oral contraceptive - Femodene.
  453. The suppression of ovarian function by the new oral contraceptive--femodene.
  454. A survey of family planning in Gondar city [letter]
  455. Survey of males gives reliable data on the use of contraceptives in D.R.
  456. Survey of men provides reliable data on contraception in the Dominican Republic. [Encuesta de varones proporciona datos confiables sobre la anticoncepcion en la Republica Dominicana.]
  457. Synthesis of work and recommendations of the Committee of Medical Experts on Hormonal Contraception. [Synthese des travaux et recommandations du Comite d'Experts Medicaux sur la Contraception Hormonale.]
  458. Synthesis of work and recommendations on voluntary surgical contraception (VSC) [Synthese des travaux et recommandations sur la contraception chirurgicale volontaire (CCV)]
  459. Taking family planning out of Title X: the impact of the proposed new regulations.
  460. Talking family planning.
  461. The task environment of family planning.
  462. Teaching contraception counseling to second-year medical students.
  463. Teaching men about contraception. Model community education outlines.
  464. Teen contraception: a review of perspectives on compliance.
  465. A tentative discussion on family planning problems in Xinjiang's minorities.
  466. Thailand: many births are unplanned despite wide contraceptive use.
  467. Thrombin generation during collection of blood from donors taking oral contraceptives.
  468. Toward a history of family planning in Portugal. 20 years of APF. [Para a historia do planeamento familiar em Portugal. Vinte anos de APF.]
  469. Trainers' reference guide for family planning counseling. Draft.
  470. Training material for maternal and child health including family planning.
  471. Training Nigerian state MOH personnel to conduct review/follow-up (progress evaluation) of family planning training programs.
  472. Transition in the midwifery profession. 25. The prewar birth control movement and the concept of eugenics.
  473. Trends and differentials in knowledge, ever use, current use, and future intended use of contraceptives in rural Bangladesh: evidence from three surveys.
  474. Trends in family intentions and the use of contraception among recent mothers, 1967-84.
  475. Trends in family size preferences and contraceptive use in Matlab, Bangladesh.
  476. Trends in health care financing: opportunities for family planning agencies.
  477. Trip report. Tunisia and Morocco, May 3-19, 1987. To conduct a survey of institutions that provide or have the potential of providing training in clinical family planning.
  478. Triphasic combined oral steroidal contraceptives. [Tristupnova oralni kombinovana steroidni kontraceptiva.]
  479. Triphasic versus monophasic oral contraceptives. [Trefasisk versus monofasisk p-pille.]
  480. Tuberculosis control assisted by family planning.
  481. Tunisia Population and Family Planning Project. 2nd semi-annual report, January 15 - July 15, 1987.
  482. The Tunisian family planning programme. [Le programme tunisien de planification familiale.]
  483. Turkey's workforce backs family planning.
  484. The U.S. international family planning program: under siege.
  485. U.S. ranked seventh in birth control availability.
  486. Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception. [Suivi echographique et hormonal des ovaires sous contraception orale minidosee.]
  487. Ultrasonically controlled retrieval of an intrauterine contraceptive device (IUCD) in early pregnancy.
  488. The under-utilization of the intrauterine device as a birth control method in the United States.
  489. Understanding adolescent contraceptive choice: an empirical test.
  490. University-Based Family Health / Family Planning Projects, Indonesia-22 Modification No. 7: project description and budget.
  491. Unmarried female worker's sexual and contraceptive knowledge and attitude.
  492. Unmet need for contraception in rural Bangladesh: evidence from a micro study.
  493. Unmet need for contraception in rural Egypt.
  494. Update on mechanical methods of postcoital contraception. Pt. 2. [Attualita in tema di contraccezione post coitale di tipo meccanico (seconda parte)]
  495. Updated pregnancy rates for the Today contraceptive sponge.
  496. Use and source of contraception in Brazil.
  497. The use of a computerized contraceptive counseling aid in family planning clinics.
  498. Use of contraceptives and fertility in Panama. [Uso de anticonceptivos y fecundidad en Panama.]
  499. Use of contraceptives by Chinese women.
  500. Use of contraceptives for family planning.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.